Mejia, Miecel C.
HRN: 23-78-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/29/2023
10/06/2023
IV INFUSION
4.5
Q8hr
Sepsis
Checking Final Appropriateness
Indication: Empirical Escalation Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes